Condition: Osteonecrosis of the Jaw · Osteonecrosis Due to Drugs, Jaw · Osteonecrosis Due to Drug · Sponsor: Catholic University of the Sacred Heart
The objective of this prospective observational study is to investigate the incidence of Medication Related Osteonecrosis of the Jaws (MRONJ) in patients receiving antiresorptive drugs for oncohematologic reasons during a 5-year follow-up. Secondary objectives are to compare the different antiresorptive drugs in relation to the incidence of MRONJ and to identify any systemic as well as local risk factors.
This description comes directly from the study's public registry record.
Carlo Lajolo, Prof. · 3356078354 · carlo.lajolo@unicatt.it
Always discuss trial participation with your own doctor first.
| Cosimo Rupe | Roma, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06457776